Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 22:15:1388176.
doi: 10.3389/fimmu.2024.1388176. eCollection 2024.

Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives

Affiliations
Review

Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives

Zhiyi Ye et al. Front Immunol. .

Abstract

The tumor microenvironment is closely linked to the initiation, promotion, and progression of solid tumors. Among its constitutions, immunologic cells emerge as critical players, facilitating immune evasion and tumor progression. Apart from their indirect impact on anti-tumor immunity, immunocytes directly influence neoplastic cells, either bolstering or impeding tumor advancement. However, current therapeutic modalities aimed at alleviating immunosuppression from regulatory cells on effector immune cell populations may not consistently yield satisfactory results in various solid tumors, such as breast carcinoma, colorectal cancer, etc. Therefore, this review outlines and summarizes the direct, dualistic effects of immunocytes such as T cells, innate lymphoid cells, B cells, eosinophils, and tumor-associated macrophages on tumor cells within the tumor microenvironment. The review also delves into the underlying mechanisms involved and presents the outcomes of clinical trials based on these direct effects, aiming to propose innovative and efficacious therapeutic strategies for addressing solid tumors.

Keywords: cancer cells; direct and dual effect; immunocytes; solid tumor; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The direct antitumor action of immune cells and the counteraction of tumor cells. Through the Fas/Fasl pathway, ADDC pathway, and TRAIL pathway, immune cells exert direct cytotoxic effects on tumor cells. Simultaneously, they can release granule enzymes, IFN-γ, TNF-α, ROS, INOS, and other mediators to generate cytotoxicity. In addition, Th9 cells induce apoptosis in tumor cells by releasing IL-9. It is noteworthy that tumor cells, in turn, enhance the cytotoxicity of NK cells and CTL cells through secretion lactic acid, TGF-β, PGE2, and VEGF-A.
Figure 2
Figure 2
The direct tumor-promoting action of immune cells and the counteraction of tumor cells. Through the secretion of multiple chemokines, cytokines and other effector molecules such as IL-4, interleukin-5, and so on, immunocytes promote tumor cells through the following ways: promoting the proliferation of tumor cells, promoting the migration and metastasis of tumor cells and promoting tumor angiogenesis. It is worth noting that tumor cells can in turn promote the activation and recruitment of macrophages and Th2 cells via secreting CCLX, IL-33, IL-4, IL-10, and M-CSF, thus promoting the formation of loops.

Similar articles

Cited by

References

    1. Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. (2019) 79:4557–66. doi: 10.1158/0008-5472.CAN-18-3962 - DOI - PMC - PubMed
    1. Bejarano L, Jordao MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discovery. (2021) 11:933–59. doi: 10.1158/2159-8290.CD-20-1808 - DOI - PubMed
    1. Czajka-Francuz P, Cison-Jurek S, Czajka A, Kozaczka M, Wojnar J, Chudek J, et al. . Systemic interleukins’ Profile in early and advanced colorectal cancer. Int J Mol Sci. (2021) 23:124. doi: 10.3390/ijms23010124 - DOI - PMC - PubMed
    1. Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. . Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. (2021) 20:131. doi: 10.1186/s12943-021-01428-1 - DOI - PMC - PubMed
    1. Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. (2020) 20:7–24. doi: 10.1038/s41577-019-0210-z - DOI - PubMed